Trump signs order to expedite psychedelic treatments for veterans
President Donald Trump signed an executive order to accelerate access to psychedelic-assisted treatments for veterans with mental health conditions such as PTSD and depression. The order directs federal agencies like the FDA, HHS, DEA, and VA to expedite research and regulatory review of substances like ibogaine. While the policy is domestically focused, Trump's recent military-related statements have prompted discussion, though markets show low concern over imminent conflict with Iran.
- ▪The executive order targets veterans suffering from PTSD, depression, substance use disorder, and suicide risk.
- ▪Federal agencies including the FDA, HHS, DEA, and VA are required to speed up research and regulatory processes for psychedelic treatments.
- ▪The initiative includes $50 million in state matching funds to support psychedelic treatment programs.
- ▪Market pricing for a US declaration of war on Iran remains low at 6.5%, indicating minimal perceived risk of escalation.
- ▪Trump’s comments on military positioning, including a hypothetical deployment to Cuba, have not significantly altered market expectations regarding Iran.
Opening excerpt (first ~120 words) tap to expand
## Market Snapshot The market for “Will the US officially declare war on Iran by December 31, 2026?” is currently priced at 6.5% YES, down from 8% a week ago. The April 30, 2026, sub-market remains at 0.1% YES, reflecting minimal immediate concern. ## Key Takeaways – Market pricing suggests that Trump’s executive order on psychedelic treatments may not directly impact the likelihood of a US declaration of war on Iran. – The recent comments by Trump about military positioning do not appear to have significantly shifted market expectations regarding a potential conflict with Iran. – The overall trend indicates a decrease in perceived risk of war, despite ongoing US-Iran tensions and naval incidents.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Crypto Briefing.
Discussion
0 commentsMore from Crypto Briefing
